Therapeutic Area Market Research Reports & Industry Analysis
Therapeutic areas include Cardiology/Vascular Diseases, Dental and Oral Health, Dermatology, Devices, Endocrinology, Family Medicine, Gastroenterology, Genetic Disease, Healthy Volunteers, Hematology, Hepatology, Immunology, Infections and Infectious Diseases, Internal Medicine, Musculoskeletal, Nephrology, Neurology, Nutrition and Weight Loss, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopedics/Orthopedic Surgery, Otolaryngology, Pediatrics/Neonatology, Pharmacology/Toxicology, Podiatry, Psychiatry/Psychology, Pulmonary/Respiratory Diseases, Rheumatology, Sleep, Trauma, Urology, and Vaccines.
Reports in these categories will contain statistics of prevalence and growth concerning therapeutic area diseases for which there are product reviews, market size, and share for products that are used in pharmaceutical treatment or equipment that used in surgical treatment of the therapeutic area.
Therapeutic Area Industry Research & Market Reports
-
Phototherapy Equipment
... CAGR of 3.5% over the analysis period 2024-2030. LED Phototherapy Equipment, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$238.9 Million by the end of the ... Read More
-
Premature Ejaculation Treatment
... at a CAGR of 7.4% over the analysis period 2024-2030. Selective Serotonin Reuptake Inhibitors (SSRIs), one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$1.8 Billion by ... Read More
-
Pregnancy Detection Kits
... at a CAGR of 4.8% over the analysis period 2024-2030. Home Pregnancy Tests (HPT), one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$805.2 Million by the ... Read More
-
Schizophrenia Therapeutics
... CAGR of 4.2% over the analysis period 2024-2030. Second Generation Antipsychotic Drugs, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$7.7 Billion by the end of ... Read More
-
Interventional Neurology Devices
... at a CAGR of 4.6% over the analysis period 2024-2030. Cerebral Embolization & Aneurysm Coiling, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$2.0 Billion by ... Read More
-
Leukemia Therapeutics
... CAGR of 5.6% over the analysis period 2024-2030. Chronic Myeloid Leukemia Therapeutics, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$9.1 Billion by the end of ... Read More
-
Diabetic Macular Edema Treatment
... 2030, growing at a CAGR of 2.2% over the analysis period 2024-2030. Anti-VEGF, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$2.7 Billion by the end ... Read More
-
Male Hypogonadism
... CAGR of 5.1% over the analysis period 2024-2030. Testosterone Replacement Therapy, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$3.5 Billion by the end of the ... Read More
-
Neuroprosthetics
... 11.9% over the analysis period 2024-2030. Spinal Cord Stimulation Technique, one of the segments analyzed in the report, is expected to record a 13.2% CAGR and reach US$11.7 Billion by the end of the analysis ... Read More
-
Non-Melanoma Skin Cancer
... at a CAGR of 4.4% over the analysis period 2024-2030. Basal Cell Carcinoma (BCC) Indication, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$835.6 Million by ... Read More
-
Oncology Information Systems
... at a CAGR of 6.2% over the analysis period 2024-2030. Software Component, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$5.5 Billion by the end of ... Read More
-
Opioids
... 2.3% over the analysis period 2024-2030. Extended-Release / Long-Acting Opioids, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$18.7 Billion by the end of the analysis ... Read More
-
Orthodontic Services
... CAGR of 11.4% over the analysis period 2024-2030. Removable Orthodontic Services, one of the segments analyzed in the report, is expected to record a 12.0% CAGR and reach US$7.7 Billion by the end of the ... Read More
-
Pneumonia Testing
... CAGR of 6.2% over the analysis period 2024-2030. Immunodiagnostics, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$339.9 Million by the end of the analysis period. ... Read More
-
Penile Implants
... CAGR of 4.3% over the analysis period 2024-2030. Inflatable Implant, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$557.9 Million by the end of the analysis ... Read More
-
Peptic Ulcer Drugs
... at a CAGR of 2.2% over the analysis period 2024-2030. Antibiotics, one of the segments analyzed in the report, is expected to record a 2.0% CAGR and reach US$2.6 Billion by the end of the ... Read More
-
Perfusion Systems
... CAGR of 4.4% over the analysis period 2024-2030. Cardiopulmonary Perfusion Systems, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$671.0 Million by the end of the ... Read More
-
Spinal Cord Trauma Treatment
... 2030, growing at a CAGR of 3.4% over the analysis period 2024-2030. Surgery, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$1.7 Billion by the end ... Read More
-
Colorectal Cancer Therapeutics
... at a CAGR of 6.5% over the analysis period 2024-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$14.9 Billion by the end of ... Read More
-
Breast Cancer Therapeutics
... at a CAGR of 12.3% over the analysis period 2024-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 12.6% CAGR and reach US$74.9 Billion by the end of ... Read More
-
Urinary Tract Infection Treatment
... 2030, growing at a CAGR of 2.5% over the analysis period 2024-2030. Quinolones, one of the segments analyzed in the report, is expected to record a 2.3% CAGR and reach US$5.2 Billion by the end ... Read More
-
Vaginal Moisturizers
... CAGR of 4.2% over the analysis period 2024-2030. Retail Stores End-Use, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$155.2 Million by the end of the ... Read More
-
Vaginal Odor Control Product
... 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. Intimate Wash, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$3.2 Billion by the ... Read More
-
Psychiatric and Substance Abuse Hospitals
... Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Alcoholism Rehabilitation Hospitals, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$13.5 ... Read More
-
Allergy Immunotherapy
... CAGR of 9.4% over the analysis period 2024-2030. Subcutaneous Immunotherapy (SCIT), one of the segments analyzed in the report, is expected to record a 10.1% CAGR and reach US$3.4 Billion by the end of the ... Read More
Research Assistance
